SMITH J. JEFFERSON

Chief Research Officer

SMITH J. JEFFERSON has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Feb 19, 2026.

On the most recent filing, SMITH J. JEFFERSON is listed as Chief Research Officer at PRECISION BIOSCIENCES INC. Inside the rolling window, SMITH J. JEFFERSON reported no open-market purchases and 2 open-market sales totaling $60K in DTIL. The largest disclosed transaction in the window is a sale of 10,200 DTIL shares on Jan 21, 2026, worth $41K.

Companies traded

Other insiders at DTIL

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$60K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
DTILSale$19KFeb 19SEC ↗
DTILSale$41KJan 22SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has SMITH J. JEFFERSON made?

SMITH J. JEFFERSON has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.

Which companies does SMITH J. JEFFERSON trade?

SMITH J. JEFFERSON has filed SEC Form 4 disclosures for 1 company, including DTIL.

When was SMITH J. JEFFERSON's most recent SEC Form 4 filing?

SMITH J. JEFFERSON's most recent SEC Form 4 filing on Tracefour is dated Feb 19, 2026.

What is SMITH J. JEFFERSON's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, SMITH J. JEFFERSON is listed as Chief Research Officer.

What is SMITH J. JEFFERSON's total buy and sell value in the current window?

Inside the rolling retention window, SMITH J. JEFFERSON bought $0 and sold $60K based on SEC Form 4 filings.

What was SMITH J. JEFFERSON's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 10,200 DTIL shares on 2026-01-21, worth $41K, per SEC Form 4 filings.